The price, and that is confidential & was negotiated for all in all , 300 zillion doses, is slightly less than the $19.50 per picture the United States agreed to buy a first shipment of hundred million doses of the same vaccine, in line with what Reuters claimed in November.
The EU document dated Nov. eighteen was circulated internally following the EU announced its supply offer with Pfizer and its German partner BioNTech on Nov. eleven.
The EU drug regulator is actually likely to decide on Monday on endorsement for the Pfizer vaccine following the shot was authorised in several countries, including Britain and also the United States.
On Thursday Belgian declare secretary for the spending budget Eva De Bleeker published on Twitter a dining room table with price tags Belgium will pay pharmaceutical companies for the COVID 19 vaccines of theirs. She retracted the content shortly after publishing.
In this dining room table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) a dose, top many to believe this was the entire fee agreed by way of the EU.
Various other vaccines in the table were additionally shown with rates lower than prices disclosed by EU sources.
“There is surely a full price along with a price after delivery,” an EU official required in talks with vaccine creators told Reuters when directed to clarify the big difference between the EU and Belgian prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted price tags were still partial.
Under EU advance purchase deals for COVID-19 vaccines, the bloc believes upfront payments with businesses to secure doses before they are approved. After approvals, EU governments can pay the rest to get reserved doses.
The EU has not revealed the upfront payment agreed with Pfizer.
However, it said in October that it paid aproximatelly one billion euros inside downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for initial payments to Pfizer-BioNTech, Curevac and Moderna.
It’s since agreed supply deals with all 6 businesses and it is negotiating a seventh agreement with Novavax.